MRMMedirom Healthcare Technologies Inc.vs its industry peers
A metric-by-metric comparison of Medirom Healthcare Technologies Inc. against SIC 7200 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRMThis | $6M#4 | — | — | — | — | — | — | — | — | — | — | — |
| WW | $165M#1 | — | 0.6x#2 | 0.2x#1 | -11.6%#3 | 405.5%#1 | -30.1%#2 | 379.0%#1 | -37.6%#2 | 4#2 | -45.0%#2 | — |
| RGS | $71M#2 | 11.7x#1 | 0.4x#1 | 0.3x#3 | 6.8%#2 | -94.4%#6 | 10.9%#1 | 3.6%#2 | 5.1%#1 | 5#1 | 2.6%#1 | — |
| XWEL | $8M#3 | — | — | 0.3x#2 | -13.8%#4 | -0.8%#5 | -53.6%#3 | — | — | 3#3 | — | — |
| BGFR | — | — | — | — | — | 6.6%#3 | — | — | — | — | — | — |
| SNTL | — | — | — | — | — | 119.7%#2 | -230.8%#5 | — | — | — | — | — |
| VGES | — | — | — | — | 159.0%#1 | -194.9%#7 | -54.5%#4 | — | — | — | — | — |
| VYND | — | — | — | — | — | 2.3%#4 | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 7200). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-23.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice